Title 21 › CHAPTER 9 — FEDERAL FOOD, DRUG, AND COSMETIC ACT › SUBCHAPTER V — DRUGS AND DEVICES › Part A — Drugs and Devices › § 360g
People hurt by certain FDA rules or orders about medical devices have 30 days to ask a U.S. Court of Appeals to review them. You can file in the D.C. Circuit or the federal circuit where you live or have your main business. The court clerk must send a copy of the petition to the Secretary. The Secretary must file the record used to make the rule or order, as required by 28 U.S.C. 2112. The law covers nine kinds of FDA actions, such as device classification changes, performance standards, premarket approval requirements, bans, reclassification decisions, investigational exemptions, and similar orders. The “record” means Federal Register notices, materials sent to the Secretary, advisory panel or committee work, hearings, and any other information the Secretary says is relevant. If the petitioner asks the court to allow new evidence, views, or arguments, the court may allow it if the new material is important and there was a good reason it was not given earlier. The court can order the Secretary to reopen the record and take more written or oral submissions. The Secretary may change or add findings and must file those with the court. The court reviews the action under the Administrative Procedure Act and may grant relief, including temporary relief. A rule that sets or changes a performance standard or bans a device, and an order after review under section 360e(g), cannot be upheld if it is unsupported by substantial evidence on the record taken as a whole. The court’s judgment is final, but the Supreme Court may review it by certiorari or certification under 28 U.S.C. 1254. The remedies here are in addition to any other legal remedies. Each covered rule or order must say why it was issued and show the record items that support it.
Full Legal Text
Food and Drugs, Source: USLM XML via OLRC
Legislative History
Reference
Citation
21 U.S.C. § 360g
Title 21, Food and Drugs
Last Updated
Sep 22, 2026
Release point: 119-110